
Expect a bumpy ride this week when FDA advisers consider Covid-19 booster shots
CNN
Last December, when FDA advisers met to consider whether the agency should authorize Pfizer's Covid-19 vaccine, it was generally understood that the answer would be yes.
Nine months later, those advisers are meeting to discuss booster shots, and the situation is very different.
It won't be a slam dunk.
More Related News

A number of Jeffrey Epstein survivors voiced their concern in a private meeting with female Democratic lawmakers earlier this week about the intermittent disclosure of Epstein-related documents and photos by Democrats on the House Oversight Committee, sharing that the selective publication of materials was distressing, four sources familiar with the call told CNN.












